Martine Bagot to Neoplasm Staging
This is a "connection" page, showing publications Martine Bagot has written about Neoplasm Staging.
Connection Strength
0.356
-
18F-fluorodeoxyglucose-positron emission tomography is more sensitive than computed tomography in initial staging of patients with an anaplastic T-cell lymphoma first presenting in the skin. Eur J Dermatol. 2017 Oct 01; 27(5):496-504.
Score: 0.102
-
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs. Eur J Dermatol. 2017 Jun 01; 27(3):286-294.
Score: 0.100
-
The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol. 2019 08; 181(2):350-357.
Score: 0.028
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2018 09; 19(9):1192-1204.
Score: 0.027
-
Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Series of 37 Cases and Systematic Review of the Literature. Acta Derm Venereol. 2018 Jul 11; 98(7):671-676.
Score: 0.027
-
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force. Eur J Cancer. 2018 04; 93:47-56.
Score: 0.026
-
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. Eur J Cancer. 2017 05; 77:57-74.
Score: 0.025
-
IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma. Cancer Res. 2014 Nov 01; 74(21):6060-70.
Score: 0.021